
Goldenwell Biotech, Inc. Share · US38138N1046 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Goldenwell Biotech, Inc.
No Price
Closing Price OTC 30.04.2026:
1,00 USD
30.04.2026 20:00
Current Prices from Goldenwell Biotech, Inc.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
GWLL
|
USD
|
30.04.2026 20:00
|
1,00 USD
| 0,00 USD |
Company Profile for Goldenwell Biotech, Inc. Share
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. The company is developing five products, including JI MAI—bovine cardiac vascular active peptide; cartilage peptide, a type II collagen peptide; and Double Proline AG 3D active collagen peptide, as well as DNA repair tablets and sugar master tablets. The company was incorporated in 2019 and is based in Twinsburg, Ohio.
Company Data
Name Goldenwell Biotech, Inc.
Company Goldenwell Biotech, Inc.
Primary Exchange
UTC
ISIN US38138N1046
Asset Class Share
Sector Consumer Defensive
Industry Packaged Foods
CEO Shuang Liu
Market Capitalization 99 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 2071 Midway Drive, 44087 Hudson
IPO Date 2022-09-30
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | GWLL |
More Shares
Investors who hold Goldenwell Biotech, Inc. also have the following shares in their portfolio:

